Parallel scientific advice and special development aspects or product types
Submitted by Anonymous (not verified) on 12 May 2026 - 15:34
Parallel scientific advice and special development aspects or product types
Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices
Submitted by Anonymous (not verified) on 12 May 2026 - 15:15
Other fees and charges for medicinal products for human use, veterinary medicinal products and consultations on medical devices
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 12 May 2026 - 15:08
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised
Submitted by Anonymous (not verified) on 12 May 2026 - 15:00
Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 12 May 2026 - 14:45
Human medicines European public assessment report (EPAR): Olazax Disperzi, olanzapine, Date of authorisation: 10/12/2009, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn
Submitted by Anonymous (not verified) on 12 May 2026 - 13:20
Human medicines European public assessment report (EPAR): Zoledronic acid Actavis, zoledronic acid, Date of authorisation: 20/04/2012, Revision: 16, Status: Withdrawn
EMA actively monitoring cruise ship Hantavirus outbreak
Submitted by Anonymous (not verified) on 12 May 2026 - 13:19
EMA actively monitoring cruise ship Hantavirus outbreak
Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn
Submitted by Anonymous (not verified) on 12 May 2026 - 13:00
Human medicines European public assessment report (EPAR): Zoledronic Acid Hospira, zoledronic acid, Date of authorisation: 19/11/2012, Revision: 19, Status: Withdrawn
EMA business hours over Ascension Day holidays, 14 and 15 May
Submitted by Anonymous (not verified) on 12 May 2026 - 13:00
EMA business hours over Ascension Day holidays, 14 and 15 May
Article 57 product data
Submitted by Anonymous (not verified) on 12 May 2026 - 12:12
Article 57 product data